Jiangsu Nhwa Pharmaceutical Co., LTD (SHE:002262)
China · Delayed Price · Currency is CNY 22.13
+0.30 (1.37%)
Aug 26, 2026, 3:04 PM CST
SHE:002262 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 6,119 | 5,911 | 5,698 | 5,042 | 4,299 | 3,936 |
Revenue Growth | 2.94% | 3.75% | 13.01% | 17.29% | 9.22% | 17.09% |
Gross Profit Gross Profit Growth | 4,332 | 4,233 | 4,152 | 3,638 | 3,262 | 3,003 |
Operating Income Operating Income Growth | 1,155 | 1,095 | 1,213 | 1,070 | 901.63 | 847.28 |
Net Income Net Income Growth | 1,098 | 1,057 | 1,144 | 1,037 | 900.71 | 797.78 |
Earnings Per Share EPS Growth | 1.09 | 1.05 | 1.13 | 1.03 | 0.89 | 0.79 |
EPS Growth | -9.17% | -7.08% | 9.71% | 15.73% | 12.66% | 9.72% |
| Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
Others Others Growth | 144.21 |
Manufacturing Manufacturing Growth | 4,990 |
Commercial Commercial Growth | 888.77 |
Intersegment Offset Intersegment Offset Growth | -111.44 |
Total Total Growth | 5,911 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 3,744 | 4,019 | 3,789 | 3,494 | 2,984 | 2,666 |
Total Debt Total Debt Growth | 72.04 | 67.72 | 69.27 | 111.64 | 92.77 | 110.91 |
Net Cash (Debt) Net Cash Growth | 3,672 | 3,951 | 3,720 | 3,382 | 2,891 | 2,555 |
Net Cash Growth | 1.79% | 6.20% | 9.99% | 16.98% | 13.16% | 16.08% |
Net Cash Per Share Net Cash Per Share Growth | 3.65 | 3.92 | 3.68 | 3.36 | 2.86 | 2.53 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 863.97 | 1,078 | 916.13 | 1,008 | 861.02 | 701.12 |
Capital Expenditures CapEx Growth | -442.64 | -437.41 | -450.06 | -373.99 | -327.75 | -206.11 |
Free Cash Flow Free Cash Flow Growth | 421.34 | 640.98 | 466.07 | 634.31 | 533.27 | 495.01 |
Free Cash Flow Growth | 6.13% | 37.53% | -26.52% | 18.95% | 7.73% | -49.48% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 70.80% | 71.61% | 72.87% | 72.17% | 75.88% | 76.30% |
Operating Margin | 18.87% | 18.53% | 21.29% | 21.22% | 20.97% | 21.53% |
Pretax Margin | 20.11% | 19.85% | 22.76% | 23.18% | 23.03% | 23.27% |
Profit Margin | 17.94% | 17.89% | 20.07% | 20.57% | 20.95% | 20.27% |
FCF Margin | 6.88% | 10.84% | 8.18% | 12.58% | 12.41% | 12.58% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.400 | 0.400 | 0.360 | 0.320 | 0.200 | 0.200 |
Dividend Per Share Growth | 11.11% | 11.11% | 12.50% | 60.00% | 0% | 100.00% |
Dividend Yield | 1.75% | 1.69% | 1.53% | 1.24% | 0.86% | 1.37% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 20.02 | 23.18 | 21.64 | 26.35 | 27.46 | 19.77 |
Forward PE | 16.92 | 19.46 | 18.59 | 22.41 | 24.31 | 17.58 |
P/FCF Ratio | 52.63 | 38.24 | 53.09 | 43.08 | 46.39 | 31.86 |
PS Ratio | 3.62 | 4.15 | 4.34 | 5.42 | 5.76 | 4.01 |